Literature DB >> 23814524

Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience.

Robert Wieder1, Randall Teal, Tracie Saunders, Bryan J Weiner.   

Abstract

The Minority-Based Community Clinical Oncology Program (MB-CCOP) at University of Medicine and Dentistry of New Jersey, New Jersey Medical School-University Hospital Cancer Center was established to serve an unmet need in a medically, educationally, and socioeconomically underserved community of primarily African American and Latino patients in Newark and Essex County, New Jersey. The MB-CCOP was built on an existing infrastructure of multidisciplinary teams of cancer specialists who collaborated in patient care and an existing clinical research program, which included multilingual staff and a breast cancer navigator. This article highlights some of the unique opportunities and challenges involved in the startup of an MB-CCOP specifically relevant to an academic setting. We present a guide to the necessary infrastructure and institutional support that must be in place before considering such a program and some of the steps an institution can take to overcome barriers preventing successful enrollment of patients onto clinical trials.

Entities:  

Mesh:

Year:  2013        PMID: 23814524      PMCID: PMC3595450          DOI: 10.1200/JOP.2012.000648

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  5 in total

1.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials.

Authors:  D R Brown; M N Fouad; K Basen-Engquist; G Tortolero-Luna
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

Review 2.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

3.  Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.

Authors:  Worta McCaskill-Stevens; Martha M McKinney; Cynthia G Whitman; Lori M Minasian
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

4.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

5.  Clinical trial participation. Viewpoints from racial/ethnic groups.

Authors:  N L Roberson
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

  5 in total
  3 in total

1.  Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology.

Authors:  Erin E Kent; Sandra A Mitchell; Kathleen M Castro; Darren A DeWalt; Arnold D Kaluzny; Judith A Hautala; Oren Grad; Rachel M Ballard; Worta J McCaskill-Stevens; Barnett S Kramer; Steven B Clauser
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

2.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14

3.  Greater Survival Improvement in African American vs. Caucasian Women with Hormone Negative Breast Cancer.

Authors:  Robert Wieder; Basit Shafiq; Nabil Adam
Journal:  J Cancer       Date:  2020-02-21       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.